103147-22-4

Upstream product

• 112-29-8 1-bromo dodecane 
• 108-46-3 recorcinol 
• 5509-08-0 decyl p-toluenesulfonate 
• 54494-87-0 resorcinol; sodium-compound 

Downstream Products

• 140468-07-1 4-(3-Decyloxy-phenoxymethyl)-2,2-dimethyl-[1,3]dioxolane 
• 128950-07-2 3-(4-Decyloxy-2-hydroxy-benzoyl)-benzoic acid 
• 1027262-85-6 2-(3-decyloxy-phenoxymethyl)-oxirane 
• 912806-38-3 1-(6-bromohexyloxy)-3-decyloxybenzene 
• 1417647-73-4 C₄₀H₅₂N₂O₄ 
• 1331960-52-1 5-decyloxy-2-(6-decyloxybenzoxazol-2-yl)phenol 
• 1331960-70-3 C₄₃H₇₁NO₅ 
• 1331960-80-5 C₁₆H₂₅NO₄ 
• 1331960-65-6 C₃₃H₅₁NO₄ 
• 1331960-57-6 2,3-didecyloxy-6-(6-decyloxybenzoxazol-2-yl)phenol 
• 140467-58-9 1-(3-Decyloxy-phenoxy)-3-[(4-methoxy-phenyl)-diphenyl-methoxy]-propan-2-ol 
• 140467-73-8 3-(3-Decyloxy-phenoxy)-2-methoxy-propan-1-ol 
• 140468-16-2 3-(3-Decyloxy-phenoxy)-propandiol-(1,2) 
• 912806-45-2 O-[6-(3-decyloxyphenyloxy)hexyl]-4,4'-bis(methoxycarbonylphenyl)methanone oxime 

Relevant academic research and scientific papers

Polarization effect in luminescent mesogenic BF2 complexes derived from heterocyclic benzothiazoles

Two series of benzo(thia)xazoles 1–2 and one series of boron difluoride complexes 2-BF2 derived from benzothiazoles 2 were reported, and their mesomorphic and optical properties were investigated. The crystal and molecular structures of compound 2 and 2-BF2 (all n = 8) were determined by means of X?ray structural analysis, and both crystallize in the triclinic P-1 and monoclinic P21/c. The geometry at boron center is perfectly tetrahedral, and the overall molecular shapes are considered as rod?shape. Both benzo(thia)xazoles 1 and 2 exhibited N or/and SmC phase, and boron complexes 2-BF2 formed N or/and SmC phase. Benzothiazoles 2 showed a much wider temperature range of mesophase than those of benzoxazoles 1, which were attributed to the better polarization by sulfur atom incorporated. Boron complexes 2-BF2 (n = 10, 12) emitted a yellow?to?green emission at λmax = 569–571 nm in CH2Cl2. This is the first mesogenic BF2 complexes derived from benzothiazoles.

Discotic liquid crystals of transition metal complexes 45?: Parity effect of the number of d-electrons on stacking distances in the columnar mesophases of octakis-(M-alkoxyphenoxy)phthalocyaninato metal(II) complexes

We have synthesized 34 novel homologous discotic liquid crystals, octakis(m-alkoxyphenoxy)phthalocyaninato metal(II) {abbreviated as (m-C nOPhO)8PcM (M = Co(1), Ni(2), Cu(3), Zn(4) and H 2(5); n = 8(a), 10(b), 12(c), 14(d)

Columnar/smectic metallomesogens derived from heterocyclic benzoxazoles

The synthesis, mesomorphic behavior, and optical properties of two new series of metal complexes 1a,b-M (M=Pd, Cu, Zn) derived from benzoxazoles 2a,b are reported. The crystal and molecular structures of mesogenic 5-decyloxy-2-(6-decyloxybenzooxazol-2-yl)

A novel class of potent nonglycosidic and nonpeptidic pan-selectin inhibitors

An early step of the inflammatory response, the rolling of leukocytes on activated endothelial cells, is mediated by selectin/carbohydrate interactions. The tetrasaccharide sialy LewisX is a ligand for E-, P-, and L-selectin and therefore serve

Design and synthesis of a novel and potent series of inhibitors of cytosolic phospholipase A2 based on a 1,3-disubstituted propan-2-one skeleton

Using knowledge of the substrate specificity of cPLA2 (phospholipases A2), a novel series of inhibitors of this enzyme were designed based upon a three point model of inhibitor binding to the enzyme active site comprising a lipophilic anchor, an electrophilic serine "trap", and an acidic binding moiety. The resulting 1,3-diheteroatom-substituted propan-2-ones were evaluated as inhibitors of cPLA2 in both aggregated bilayer and soluble substrate assays. Systematic variation of the lipophilic, electrophilic, and acidic groups revealed a well-defined structure-activity relationship against the enzyme. Optimization of each group led to compound 22 (AR-C70484XX), which contains a decyloxy lipophilic side chain, a 1,3-diaryloxypropan-2-one moiety as a unique serine trap, and a benzoic acid as the acidic binding group. AR-C70484XX was found to be among the most potent in vitro inhibitors of cPLA2 described to date being more than 20-fold more active against the isolated enzyme (IC50 = 0.03 μM) than the standard cPLA2 inhibitor, arachidonyl trifluoromethyl ketone (AACOCF3), and also greater than 10-fold more active than AACOCF3 against the cellular production of arachidonic acid by HL60 cells (IC50 = 2.8 μM).